bioRxiv Science⌕ Search

Biology subjects

Chaiboonchoe, A.

Publications and source records attributed to Chaiboonchoe, A..

2 recordsLinked to original sources

Multi-omics decipher the molecular mechanisms driving high-lipid production in an artificially-evolved Chlamydomonas mutant

Enhancing lipid accumulation in microalgae is critical for commercial viability but often compromises growth. We previously identified an artificially evolved Chlamydomonas reinhardtii mutant (H5) that retains wild-type growth (CC-503) while producing significantly more lipids. Here, we present multi-omic analyses that elucidate the molecular basis of this phenotype. Whole-genome sequencing revealed over 3,000 mutations in H5, including 45 in protein-coding genes (e.g., phosphofructokinase, acyl-carrier protein, glycerol kinase). Six corresponding CLiP insertion mutants also showed elevated lipid content. Transcriptomics revealed upregulation of key genes for glycolysis, nutrient uptake, and proliferation (e.g., pyruvate carboxylase, carbonic anhydrase) under nutrient-replete conditions. Metabolomics identified a striking increase in malonate, a metabolite that supports fatty acid synthesis and cell proliferation. Epigenomic profiling showed hypomethylation in triacylglycerol (TAG) biosynthesis genes and hypermethylation in energy balance regulators. Together, these data suggest that accelerated glycolysis and streamlined metabolism drive lipid accumulation in H5 without compromising growth. Our findings provide a blueprint for engineering high-lipid microalgal strains for industrial applications. HIGHLIGHTSO_LIHigh-lipid Chlamydomonas mutant (H5) exhibits cancer-like metabolism: pseudo-hypoxia and nutrient deprivation response C_LIO_LIMulti-omics reveals 45 high-impact mutations synergistically enhance lipid production in H5 C_LIO_LISix CLiP mutants of H5-disrupted genes showed significantly increased lipid content C_LIO_LIMalonate levels increased 10-fold in H5, indicating altered mitochondrial function C_LIO_LIH5 upregulates glycolytic genes while maintaining wild-type growth rates C_LIO_LITranscriptomes from H5 and CC-503 converge after nitrogen deprivation despite replete-state differences C_LIO_LIH5 shows altered lipid composition with increased TAG diversity, decreased DAGs C_LIO_LIEpigenomic profiling reveals 14,720 differentially methylated transcribed regions in H5 C_LI

genomics↗

Time-Resolved Transcriptomics Reveal Spliceosomal Disruption and Senescence Pathways in Crocin-Treated Hepatocellular Carcinoma Cells

Saffron-derived crocin exhibits anti-cancer properties, but the pathways underlying its effects remain incompletely characterized. Here, we utilized a high-dose perturbation strategy (1-2 mM crocin) to probe maximal pathway engagement in HepG2 hepatocellular carcinoma cells via time-series transcriptomics. We treated cells for 2, 6, 12, and 24 h and analyzed transcriptomic and splicing profiles at each timepoint. We identified 7400-12,100 differentially expressed genes (DEGs) per condition, with the higher dose (CR2) producing more total DEGs but the lower dose (CR1) demonstrating differential pathway prioritization. The spliceosome pathway ranked first among downregulated pathways for CR1 across multiple timepoints (false discovery rate, FDR p = 10-21 to 10-36) but only fourth for CR2, suggesting dose-dependent differences in pathway prioritization. Differential splicing analysis revealed functional spliceosome disruption, with 2000-2600 significant exon skipping events per condition and aberrant splicing of spliceosome components including HNRNPH1 (change in percent spliced in, dPSI = -0.78 to -0.89). Additionally, 66 genes implicated in non-alcoholic fatty liver disease were downregulated at 24 h (FDR p = 8x10-8). Crocin exposure consistently downregulated spliceosomal machinery genes while upregulating senescence and autophagy pathways. These findings identify spliceosome components and RNA processing machinery as crocin-sensitive pathways.

cancer biology↗